Gossamer Bio GOSS
NASDAQ GOSS
$11.28 +0.63 (+5.97%)
At close: Nov 10, 2026 · 4:00 PM EST

Gossamer Bio (GOSS) EV to CFO (2025)

Updated

Gossamer Bio's (GOSS) EV to CFO came in at -0.88 for Q1 2025.

Analysis

Gossamer Bio (GOSS) EV to CFO (2025) Analysis & Trends

For the trailing twelve months through Mar 31, 2025, EV to CFO at Gossamer Bio was -108.02.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Gossamer Bio 45.16 Mn -428.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -0.88
API Access

Gossamer Bio EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=GOSS&period=max&api_key=YOUR_API_KEY